Replimune Group, Inc.
REPL
DELAYED 1 MONTH
7 insider filings · Latest: Jun 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | Jun 4 12:30 AM | Christopher SarchiChief Commercial Officer | Sale | 12,000 | $9.24 | $110.9K | 180,962(D) | View → |
| May 18, 2026 | May 20 8:18 PM | Konstantinos XynosChief Medical Officer | Sale | 14,023 | $5.08 | $71.2K | 235,662(D) | View → |
| May 18, 2026 | May 20 8:17 PM | Andrew SchwendenmanChief Accounting Officer | Sale | 7,894 | $5.08 | $40.1K | 107,057(D) | View → |
| May 18, 2026 | May 20 8:16 PM | Christopher SarchiChief Commercial Officer | Sale | 8,626 | $5.08 | $43.8K | 192,962(D) | View → |
| May 18, 2026 | May 20 8:16 PM | Philip Astley-SparkeDirector | Sale | 17,657 | $5.08 | $89.7K | 1,412,414(D) | View → |
| May 18, 2026 | May 20 8:15 PM | Sushil PatelDirector, Chief Executive Officer | Sale | 37,324 | $5.08 | $189.6K | 747,492(D) | View → |
| May 18, 2026 | May 20 8:15 PM | Emily Luisa HillChief Financial Officer | Sale | 7,812 | $5.08 | $39.7K | 236,556(D) | View → |
Stock Options & Derivatives
No transactions found.